These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31444566)

  • 1. Severe parkinsonism under treatment with antipsychotic drugs.
    Druschky K; Bleich S; Grohmann R; Engel RR; Toto S; Neyazi A; Däubl B; Stübner S
    Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):35-47. PubMed ID: 31444566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project.
    Druschky K; Bleich S; Grohmann R; Engel RR; Neyazi A; Stübner S; Toto S
    World J Biol Psychiatry; 2019 Nov; 20(9):732-741. PubMed ID: 30058414
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe hair loss associated with psychotropic drugs in psychiatric inpatients-Data from an observational pharmacovigilance program in German-speaking countries.
    Druschky K; Bleich S; Grohmann R; Burda K; Frieling H; Hillemacher T; Neyazi A; Stübner S; Toto S
    Eur Psychiatry; 2018 Oct; 54():117-123. PubMed ID: 30193142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015.
    Glocker C; Grohmann R; Engel R; Seifert J; Bleich S; Stübner S; Toto S; Schüle C
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1425-1435. PubMed ID: 33768297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study.
    Druschky K; Toto S; Bleich S; Baumgärtner J; Engel RR; Grohmann R; Maier HB; Neyazi A; Rudolph YJ; Rüther E; Schwörer H; Seifert J; Stübner S; Degner D
    World J Biol Psychiatry; 2021 Jun; 22(5):373-386. PubMed ID: 32892689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical dyskinesias under treatment with antipsychotic drugs: Report from the AMSP multicenter drug safety project.
    Baumgärtner J; Grohmann R; Bleich S; Glocker C; Seifert J; Toto S; Rüther E; Engel RR; Stübner S
    World J Biol Psychiatry; 2022 Feb; 23(2):151-164. PubMed ID: 34096837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Adverse Reactions During Antipsychotic Treatment: Results of AMSP, A Drug Surveillance Program Between 1993 and 2013.
    Friedrich ME; Winkler D; Konstantinidis A; Huf W; Engel R; Toto S; Grohmann R; Kasper S
    Int J Neuropsychopharmacol; 2020 Feb; 23(2):67-75. PubMed ID: 31504560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
    de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
    Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016.
    Glocker C; Grohmann R; Burkhardt G; Seifert J; Bleich S; Held T; Toto S; Stübner S; Schüle C
    J Neural Transm (Vienna); 2023 Feb; 130(2):153-163. PubMed ID: 36653686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993-2015.
    Schneider M; Regente J; Greiner T; Lensky S; Bleich S; Toto S; Grohmann R; Stübner S; Heinze M
    Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):23-33. PubMed ID: 30506147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance programme.
    Letmaier M; Grohmann R; Kren C; Toto S; Bleich S; Engel R; Gary T; Papageorgiou K; Konstantinidis A; Holl AK; Painold A; Kasper S
    World J Biol Psychiatry; 2018 Apr; 19(3):175-186. PubMed ID: 28112047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017.
    Seifert J; Maier HB; Führmann F; Bleich S; Stübner S; Sieberer M; Bernegger X; Greil W; Schüle C; Toto S; Grohmann R; Reinhard MA
    J Neural Transm (Vienna); 2022 Jul; 129(7):925-944. PubMed ID: 35524828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016.
    Bleich L; Grohmann R; Greil W; Dabbert D; Erfurth A; Toto S; Seifert J
    J Neural Transm (Vienna); 2024 Sep; 131(9):1117-1134. PubMed ID: 39136776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
    Greil W; Häberle A; Schuhmann T; Grohmann R; Baumann P
    Swiss Med Wkly; 2013; 143():w13772. PubMed ID: 23821346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - A drug surveillance report from German-speaking countries.
    Winkler D; Grohmann R; Friedrich ME; Toto S; Bleich S; Seifert J; Konstantinidis A; Shariat SF; Kasper S; Pjrek E
    J Psychiatr Res; 2021 Dec; 144():412-420. PubMed ID: 34741839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
    Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs.
    Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
    Eur J Clin Pharmacol; 2001 Jul; 57(4):327-31. PubMed ID: 11549212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.
    Spindelegger CJ; Papageorgiou K; Grohmann R; Engel R; Greil W; Konstantinidis A; Agelink MW; Bleich S; Ruether E; Toto S; Kasper S
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001-2017.
    Seifert J; Engel RR; Bernegger X; Führmann F; Bleich S; Stübner S; Sieberer M; Greil W; Toto S; Grohmann R
    J Affect Disord; 2021 Feb; 281():547-556. PubMed ID: 33401143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.
    Mentzel CL; Bakker PR; van Os J; Drukker M; Matroos GE; Hoek HW; Tijssen MA; van Harten PN
    J Clin Psychiatry; 2017 Mar; 78(3):e279-e285. PubMed ID: 28199071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.